NSG 5240 Advanced Pharmacology
Final Practice Exam;Comprehensive
Question Bank with Evidence-Based
Answers, Rationales, and Clinical
Pearls for the 2026-2027 Academic
Year
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A patient with liver cirrhosis is prescribed a drug that normally undergoes
extensive first-pass metabolism. The nurse practitioner anticipates:
A) Decreased bioavailability
B) Significantly increased bioavailability ✓
C) No change in drug levels
D) Increased first-pass metabolism
Rationale: Liver impairment means less drug is metabolized before
reaching systemic circulation, leading to higher bioavailability and potential
toxicity. First-pass metabolism occurs when orally administered drugs are
absorbed from the GI tract and transported via the portal vein to the liver,
where they are partially metabolized before reaching systemic circulation .
Hepatic dysfunction reduces this metabolic capacity .
,Question 2
A drug has a half-life of 12 hours. How many hours will it take to reach
steady state?
A) 24 hours
B) 36 hours
C) 48 hours
D) 60 hours ✓
Rationale: Steady state is achieved after approximately 4-5 half-lives. 5 ×
12 hours = 60 hours. At 4 half-lives, approximately 94% of steady state is
reached; at 5 half-lives, approximately 97% is reached . This is the time
required for drug accumulation and elimination to reach equilibrium with
dosing.
Question 3
Which route of administration bypasses the first-pass effect?
A) Oral
B) Sublingual
C) Rectal
D) Both sublingual and rectal ✓
Rationale: Sublingual and rectal routes allow drug absorption directly into
systemic circulation, avoiding portal circulation and hepatic first-pass
metabolism . Oral administration undergoes first-pass metabolism as drugs
are absorbed from the GI tract and transported via the portal vein to the
liver.
,Question 4
Which cytochrome P450 enzyme is responsible for metabolizing the largest
number of drugs?
A) CYP1A2
B) CYP2C9
C) CYP2D6
D) CYP3A4 ✓
Rationale: CYP3A4 metabolizes over 50% of all drugs and is
inhibited/induced by many agents (e.g., grapefruit juice, rifampin,
ketoconazole). This makes it the most clinically significant CYP450 enzyme
for drug interactions .
Question 5
A patient develops tolerance to morphine after chronic use. This is most
likely due to:
A) Decreased absorption
B) Increased renal excretion
C) Receptor downregulation ✓
D) Increased plasma protein binding
Rationale: Chronic agonist exposure often leads to receptor
downregulation or desensitization, requiring higher doses for the same
, effect. This is a key pharmacodynamic adaptation that contributes to opioid
tolerance .
Question 6
A patient is on rifampin (a CYP3A4 inducer) and an oral contraceptive. The
NP should:
A) Increase contraceptive dose
B) Switch to depot medroxyprogesterone
C) Recommend backup contraception ✓
D) No interaction is expected
Rationale: CYP inducers like rifampin increase the synthesis of
metabolizing enzymes, accelerating biotransformation. The substrate drug
(oral contraceptive hormones) is cleared more rapidly, leading to decreased
serum concentrations and potential therapeutic failure—in this case,
increased risk of unintended pregnancy .
Question 7
What is the primary clinical implication for an Advanced Practice Nurse
when prescribing a drug with a narrow therapeutic index?
A) The drug is safe without frequent monitoring
B) There is a small margin between the effective and toxic dose ✓
C) The drug has a very long half-life
D) The drug is exclusively metabolized by the liver
Final Practice Exam;Comprehensive
Question Bank with Evidence-Based
Answers, Rationales, and Clinical
Pearls for the 2026-2027 Academic
Year
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A patient with liver cirrhosis is prescribed a drug that normally undergoes
extensive first-pass metabolism. The nurse practitioner anticipates:
A) Decreased bioavailability
B) Significantly increased bioavailability ✓
C) No change in drug levels
D) Increased first-pass metabolism
Rationale: Liver impairment means less drug is metabolized before
reaching systemic circulation, leading to higher bioavailability and potential
toxicity. First-pass metabolism occurs when orally administered drugs are
absorbed from the GI tract and transported via the portal vein to the liver,
where they are partially metabolized before reaching systemic circulation .
Hepatic dysfunction reduces this metabolic capacity .
,Question 2
A drug has a half-life of 12 hours. How many hours will it take to reach
steady state?
A) 24 hours
B) 36 hours
C) 48 hours
D) 60 hours ✓
Rationale: Steady state is achieved after approximately 4-5 half-lives. 5 ×
12 hours = 60 hours. At 4 half-lives, approximately 94% of steady state is
reached; at 5 half-lives, approximately 97% is reached . This is the time
required for drug accumulation and elimination to reach equilibrium with
dosing.
Question 3
Which route of administration bypasses the first-pass effect?
A) Oral
B) Sublingual
C) Rectal
D) Both sublingual and rectal ✓
Rationale: Sublingual and rectal routes allow drug absorption directly into
systemic circulation, avoiding portal circulation and hepatic first-pass
metabolism . Oral administration undergoes first-pass metabolism as drugs
are absorbed from the GI tract and transported via the portal vein to the
liver.
,Question 4
Which cytochrome P450 enzyme is responsible for metabolizing the largest
number of drugs?
A) CYP1A2
B) CYP2C9
C) CYP2D6
D) CYP3A4 ✓
Rationale: CYP3A4 metabolizes over 50% of all drugs and is
inhibited/induced by many agents (e.g., grapefruit juice, rifampin,
ketoconazole). This makes it the most clinically significant CYP450 enzyme
for drug interactions .
Question 5
A patient develops tolerance to morphine after chronic use. This is most
likely due to:
A) Decreased absorption
B) Increased renal excretion
C) Receptor downregulation ✓
D) Increased plasma protein binding
Rationale: Chronic agonist exposure often leads to receptor
downregulation or desensitization, requiring higher doses for the same
, effect. This is a key pharmacodynamic adaptation that contributes to opioid
tolerance .
Question 6
A patient is on rifampin (a CYP3A4 inducer) and an oral contraceptive. The
NP should:
A) Increase contraceptive dose
B) Switch to depot medroxyprogesterone
C) Recommend backup contraception ✓
D) No interaction is expected
Rationale: CYP inducers like rifampin increase the synthesis of
metabolizing enzymes, accelerating biotransformation. The substrate drug
(oral contraceptive hormones) is cleared more rapidly, leading to decreased
serum concentrations and potential therapeutic failure—in this case,
increased risk of unintended pregnancy .
Question 7
What is the primary clinical implication for an Advanced Practice Nurse
when prescribing a drug with a narrow therapeutic index?
A) The drug is safe without frequent monitoring
B) There is a small margin between the effective and toxic dose ✓
C) The drug has a very long half-life
D) The drug is exclusively metabolized by the liver
